Inclusion Criteria:  Patients with breast cancer (18-70 years old) Patients who are planning to undergo trastuzumab for the first time  Exclusion Criteria:  Organic heart disease such as coronary heart disease, heart valve disease, cardiomyopathy liver and kidney failure severe cerebrovascular disease chronic obstructive pulmonary disease rheumatic immune system disease other tumors